Blog
Insights on using AI to search for the cure of cancer

Recent research from the University of Miami has spotlighted a concerning trend: young women are increasingly encouraged by social media to seek a tan. This trend, while seemingly harmless and...
Read more →
Navigating the complex world of cancer research can often feel overwhelming. With so much information available, patients, caregivers, and advocates may find it challenging to sift through the dense...
Read more →
Recent research from Yale University has shed light on a critical yet often overlooked aspect of cancer risk: the impact of neighborhood socioeconomic factors on the likelihood of developing...
Read more →
Navigating the world of cancer research can feel overwhelming. With an abundance of constantly evolving information, from clinical trials to the latest scientific studies, it can be challenging for...
Read more →
Recent advancements in technology are bringing a wave of hope to the pediatric cancer community. A notable development is the launch of the WeTrials platform by Beat Childhood Cancer at Penn State...
Read more →
Transforming Pediatric Cancer Research: WeTrials AI Platform Launches to Empower Families
July 7, 2026
In a significant stride towards enhancing pediatric cancer research, the Beat Childhood Cancer organization has launched the WeTrials AI patient engagement platform at Penn State College of Medicine....
Read more →
In the fight against cancer, every effort counts. At Cure Cancer With AI , we are dedicated to providing valuable resources and information about the latest advancements in cancer research, including...
Read more →
Recent research has illuminated a fascinating connection between the gut microbiome and cancer, suggesting that the tiny organisms residing in our intestines are far more than passive bystanders. As...
Read more →
FDA Approves New Therapy for Double-Positive Metastatic Breast Cancer: A Step Forward in Precision Oncology
July 7, 2026
The recent announcement of the U.S. Food and Drug Administration's (FDA) approval of a new therapy for "double-positive" metastatic breast cancer marks a significant milestone in cancer treatment...
Read more →
The recent FDA approval of a new therapeutic regimen for "double-positive" metastatic breast cancer marks a significant milestone in cancer research and treatment. The findings from the phase 3...
Read more →
Every step toward understanding and combating cancer is a step in the right direction. At Cure Cancer With AI , we are dedicated to providing valuable insights and up-to-date information on cancer...
Read more →
In a groundbreaking study published in the Journal of the National Comprehensive Cancer Network (JNCCN), researchers have highlighted the importance of timely nudges in facilitating crucial...
Read more →
Recent findings from a global phase 3 trial have ignited hope for patients battling relapsed multiple myeloma, a challenging form of blood cancer. The study reveals that a novel treatment regimen...
Read more →
At Cure Cancer With AI , our mission is to provide you with essential resources and information on cancer research , AI advancements in oncology, clinical trials, and the latest news in the field. We...
Read more →
Recent advancements in cancer research have illuminated the intricate world of DNA regulation, a breakthrough that could pave the way for more effective treatments. Scientists from the Cancer Science...
Read more →
Cancer research is a rapidly evolving field, with new studies, clinical trials, and treatment advancements emerging almost daily. However, keeping up with this wealth of information can be...
Read more →
In a groundbreaking development, researchers from the Cancer Science Institute of Singapore (CSI Singapore) have unveiled a novel method called qChIP-MS, designed to provide deeper insights into how...
Read more →
Recent advancements in cancer treatment continue to inspire hope for patients and the research community alike. A new study has shown that a combination of drugs, including an innovative...
Read more →
The MAMMAL drug–target interaction API, accessible via POST /api/v1/mammal/dti , is a powerful tool within the free Cure Cancer With AI public API that addresses a critical challenge in the field of...
Read more →
Advancing Cancer Treatment: A New Hope with Dual Payload ADCs for Gastrointestinal Cancers
July 6, 2026
In a significant breakthrough for cancer treatment, Lonza has formed an exclusive agreement with Antharis Therapeutics to develop next-generation dual-payload antibody-drug conjugates (ADCs)...
Read more →